Welcome To The Mannkind HUB On AGORACOM
Edit this title from the Fast Facts Section
  • Demo Video
  • Private Messages
  • Edit My Profile
  • View/Edit Portfolio

AGORACOM News Flash

Supreme Discusses Progress of 342K sqf. Medical Marijuana Production Facility

WATCH INTERVIEW NOW!

  • Significant progress made at its 342,000 square foot greenhouse facility located in Kincardine, Ontario
  • Moving quickly to implement its proposed plan to produce up to 24,000,000 grams of medical marijuana
  • Recently completed $1.7M financing
  • Received conditional pre-approval letter from Health Canada

Hub On AGORACOM / Corporate Profile / Watch Interview!

Message: Afrezza sales could be higher than Exubera, says Summer Street

Barney-fife-crop-fix
Rank: [?]
President
Points: [?]
5492
Rating: [?]
Votes: 21 Score: 4.5
  • Currently 4.5/5 Stars.
Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.

Afrezza sales could be higher than Exubera, says Summer Street

posted on Jul 16, 13 09:52AM

"Summer Street believes that if approved, sales of MannKind's (MNKD) inhalable insulin Afrezza could be "substantially higher" than Pfizer’s (PFE) Exubera given Afrezza’s ease of use. However, the firm adds that it cannot accurately predict future sales of Afrezza at this time."

http://www.theflyonthewall.com/permalinks/entry.php/MNKD;PFEid1858409/MNKD;PFE-Afrezza-sales-could-be-higher-than-Exubera-says-Summer-Street

New Message

Please login to post a reply

AGORACOM Quick Tips

AGORACOM Twitter. Follow our small but powerful market tips .. Follow and Prosper

President's D.D.

Here's the latest Griffin report read more

Stock Quote

Hub Leaders